David Bacskai is currently an RTSM Design Lead within Clinical Supply Chain at Janssen. In his current role of RTSM Design Lead, David leads the development and design for IRT studies in the Oncology and CAR-T therapeutic areas. David also ensures current CAR-T and Oncology IRT Best Practices are implemented to promote consistency across all trials. David has been in the IRT industry for over 20 years. During his career, David has worked at an IRT vendor and sponsor where he has had the opportunity to lead process improvement initiatives, lead User Acceptance Testing efforts at both platform and protocol level, and support standards implementation/change control
